| scholarly article | Q13442814 |
| P2093 | author name string | Chien-Sheng Chen | |
| Feng-Hsiang Chung | |||
| Te-Yao Hsu | |||
| Jyun-Mu Lin | |||
| Ching-Chang Tsai | |||
| Hsuan-Ning Hung | |||
| Yun-Ju Lai | |||
| Hsin-Hsin Cheng | |||
| Mai-Huong Thi Nguyen | |||
| P2860 | cites work | Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells | Q23910949 |
| Magnesium supplementation in pregnancy | Q24197496 | ||
| Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems | Q24245026 | ||
| Antiplatelet agents for preventing pre-eclampsia and its complications | Q24245285 | ||
| Classifying gene expression profiles from pairwise mRNA comparisons | Q24681960 | ||
| Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis | Q26825271 | ||
| Is inflammation the cause of pre-eclampsia? | Q27007059 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| Soluble endoglin contributes to the pathogenesis of preeclampsia | Q28244053 | ||
| Novel biomarkers for predicting preeclampsia | Q28386182 | ||
| Acute maternal infection and risk of pre-eclampsia: a population-based case-control study | Q28536631 | ||
| Prion infection-impaired functional blocks identified by proteomics enlighten the targets and the curing pathways of an anti-prion drug. | Q30358827 | ||
| Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion | Q33316902 | ||
| Discovering sequence motifs with arbitrary insertions and deletions | Q33330862 | ||
| The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community | Q33930523 | ||
| Systematic lipidomic analysis of yeast protein kinase and phosphatase mutants reveals novel insights into regulation of lipid homeostasis | Q34338023 | ||
| Diagnosis and management of pre-eclampsia: an update | Q34345684 | ||
| Latest advances in understanding preeclampsia | Q34425288 | ||
| Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. | Q34514153 | ||
| First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction | Q34647428 | ||
| Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? | Q34792369 | ||
| Protein microarrays and biomarkers of infectious disease | Q35002206 | ||
| Pre-eclampsia: pathophysiology, diagnosis, and management | Q35141777 | ||
| Applications of protein microarrays for biomarker discovery | Q35170387 | ||
| Growth in utero and serum cholesterol concentrations in adult life | Q35190708 | ||
| Microbiome of the placenta in pre-eclampsia supports the role of bacteria in the multifactorial cause of pre-eclampsia | Q35506794 | ||
| Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya | Q36148976 | ||
| Podocyturia as a diagnostic marker for preeclampsia amongst high-risk pregnant patients | Q36205618 | ||
| Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor | Q36360704 | ||
| Mechanisms of disease: Pre-eclampsia | Q36577103 | ||
| Serum-alpha2-macroglobulin, transferrin, albumin, and IgG levels in preeclampsia | Q36621505 | ||
| Immunoregulation in normal pregnancy and pre-eclampsia: an overview | Q36684096 | ||
| High viral load and elevated angiogenic markers associated with increased risk of preeclampsia among women initiating highly active antiretroviral therapy in pregnancy in the Mma Bana study, Botswana | Q36930454 | ||
| Maternal infection and risk of preeclampsia: systematic review and metaanalysis | Q37047930 | ||
| Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. | Q37106725 | ||
| Biomarkers for the management of pre-eclampsia in pregnant women. | Q37156676 | ||
| Prenatal Chlamydia trachomatis infection increases the risk of preeclampsia | Q37177830 | ||
| Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip | Q37294404 | ||
| Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? | Q37366512 | ||
| First-trimester maternal serum PP13 in the risk assessment for preeclampsia. | Q37444801 | ||
| Urinary tract infection during pregnancy, angiogenic factor profiles, and risk of preeclampsia | Q40960420 | ||
| Simple decision rules for classifying human cancers from gene expression profiles | Q41735339 | ||
| Is infection a major risk factor for preeclampsia? | Q43715057 | ||
| Evidence of periopathogenic microorganisms in placentas of women with preeclampsia | Q46339714 | ||
| Serum concentrations of immunoglobulins and acute phase proteins in Nigerian women with preeclampsia | Q46340269 | ||
| Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. | Q50779076 | ||
| Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia. | Q51791219 | ||
| Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. | Q51914188 | ||
| Preeclampsia. A nested, case-control study of risk factors and their interactions. | Q52302409 | ||
| Urinary podocyte excretion as a marker for preeclampsia. | Q53562117 | ||
| Antibody Profiling of Bipolar Disorder Using Escherichia coli Proteome Microarrays. | Q54263246 | ||
| Infant Growth and Stroke in Adult Life | Q57403019 | ||
| Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia | Q58377198 | ||
| Effect of pregnancy associated hypertension on immunoglobulin levels in newborns | Q68012035 | ||
| Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia | Q73399793 | ||
| Is preeclampsia an infectious disease? | Q77153770 | ||
| Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion | Q79685499 | ||
| Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia | Q80496353 | ||
| Altered expression of angiogenesis-related placental genes in pre-eclampsia associated with intrauterine growth restriction | Q80580266 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P921 | main subject | Escherichia coli | Q25419 |
| P577 | publication date | 2017-12-28 | |
| P1433 | published in | Molecular & Cellular Proteomics | Q6895932 |
| P1476 | title | Antigen Analysis of Pre-Eclamptic Plasma Antibodies Using Escherichia Coli Proteome Chips |
Search more.